Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05263037 · ClinicalTrials.gov registry record · NA

EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain

A NA study of Depression and Anxiety, sponsored by AppliedVR.

Active
Registry status
NA
Development phase
1,093
Enrollment target
1
Study location

NCT05263037 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by AppliedVR. The registered enrollment target is 1,093 participants, above the 785-participant average among 679 other Depression trials with a reported enrollment target (39% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05263037, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by AppliedVR.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,093 participants
Enrollment target
1
Study location

Study Summary

The aim of this randomized controlled trial (RCT) is to assess outcomes for virtual reality therapy (including pain intensity, pain interference, anxiety, depression, physical function, sleep, behavioral skills development, health outcomes and satisfaction) along with healthcare utilization and costs in participants with Chronic Low Back Pain.

Interventions

  • DEVICE Sham VR
  • DEVICE EaseVRx

Study Locations (1)

California

  • AppliedVR - Van Nuys

Trial Details

FieldValue
Enrollment Target 1,093 participants
Start Date 2022-01-31
Est. Completion 2026-06
Phase NA

Sponsor

AppliedVR

5 total trials

What the Registry Record Tells You About NCT05263037

The ClinicalTrials.gov registry entry for NCT05263037 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,093 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 785-participant average among 679 other Depression trials with a reported enrollment target (39% higher). The listed sponsor is AppliedVR, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Sham VR is the first listed.

NCT05263037 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05263037 about?

NCT05263037 is a clinical study titled "EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain". The aim of this randomized controlled trial (RCT) is to assess outcomes for virtual reality therapy (including pain intensity, pain interference, anxiety, depression, physical function, sleep, behavioral skills development, health outcomes and satisfaction) along with healthcare utilization and cost...

What is the current status of trial NCT05263037?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,093 participants. The study started on 2022-01-31. Estimated completion is 2026-06.

What conditions does trial NCT05263037 study?

This clinical trial studies the following conditions: Depression, Anxiety, Chronic Low Back Pain.

What interventions are being tested in trial NCT05263037?

The interventions under investigation include: Sham VR (DEVICE), EaseVRx (DEVICE).

Who is sponsoring clinical trial NCT05263037?

This trial is sponsored by AppliedVR, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05263037 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.